摘要 |
Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4 </SUP>and R<SUP>5 </SUP>are H, alkyl or alkoxyalkyl; R<SUP>6 </SUP>is H, alkyl, hydroxyalkyl or -CH<SUB>2</SUB>F; R<SUP>7</SUP>, R<SUP>8 </SUP>and R<SUP>9 </SUP>are H, alkyl, alkoxy, alkylthio, alkoxyalkyl, halo or -CF<SUB>3</SUB>; and Z is optionally substituted aryl, heteroaryl or heteroaryl-alkyl are disclosed. Also disclosed is the use of compounds of formula I in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.
|